Cochrane · systematic review · CD013197

Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure

Bijkerk, V, Jacobs, LMC, Albers, KI, et al. · Cochrane Database of Systematic Reviews · 2024 · Cochrane Library

Hepato-BiliaryAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
10
current version
GRADE rated
6
No studies
4
Included studies
NR
No studies 4 · 40%Ungraded 0 · 0%Very low 5 · 50%Low 0 · 0%Moderate 1 · 10%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Summary of findings table ‐ Deep neuromuscular blockade (NMB) compared to moderate NMB in adults undergoing intra‐ and transperitoneal laparoscopic procedures

Population: adults undergoing intra‐ and transperitoneal laparoscopic procedures
4 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality short‐term
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs moderate NMB
Peto OR 7.22 [0.45, 115.43]12 studies · 1390 participantsVery low
Downgraded: risk of bias, imprecision
Health‐related quality of life
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs moderate NMB
no estimate extracted5 studies · 440 participantsModerate
Downgraded: risk of bias
Serious adverse events (SAEs) start of surgery until 8 hours after surgery
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs moderate NMB
Peto OR 0.95 [0.59, 1.52]21 studies · 2231 participantsVery low
Downgraded: risk of bias, imprecision
Short‐term serious adverse events (SAEs)
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs moderate NMB
Peto OR 0.9 [0.56, 1.42]16 studies · 1764 participantsVery low
Downgraded: risk of bias, imprecision

Summary of findings table ‐ Deep neuromuscular blockade (NMB) compared to shallow NMB in adults undergoing intra‐ and transperitoneal laparoscopic procedures

Population: adults undergoing intra‐ and transperitoneal laparoscopic procedures
3 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality ‐ not reported
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs shallow NMB
no estimate extractedNRNo studies
Health‐related quality of life ‐ not reported
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs shallow NMB
no estimate extractedNRNo studies
Short‐term serious adverse events (SAEs)
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs shallow NMB
RR 1.66 [0.5, 5.57]2 studies · 158 participantsVery low
Downgraded: risk of bias, imprecision

Summary of findings table ‐ Deep neuromuscular blockade (NMB) compared to no NMB in adults undergoing intra‐ and transperitoneal laparoscopic procedures

Population: adults undergoing intra‐ and transperitoneal laparoscopic procedures
3 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality start of surgery ‐ not reported
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs no NMB
no estimate extractedNRNo studies
Health‐related quality of life ‐ not reported
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs no NMB
no estimate extractedNRNo studies
Serious adverse events (SAEs) start of surgery until 8 hours after surgery
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs no NMB
no estimate extracted1 study · 25 participantsVery low
Downgraded: risk of bias, imprecision